Olanzapine tablets work to treat schizophrenia, moderate to severe manic episodes and to prevent relapses in bipolar disorder.
The drug is a psychoblocker, an antipsychotic that selectively reduces the firing of dopaminergic neurons in the limbic system of the midbrain. Therefore, the drug is clinically used for the treatment of schizophrenia, moderate to severe manic episodes and the prevention of relapse of bipolar disorder.
There are adverse reactions such as dizziness, drowsiness, dry mouth, weight gain, arthralgia, and rash after the use of the drug.
It is contraindicated in patients who are hypersensitive to any of the components of the product; in patients at risk of narrow-angle glaucoma; and in patients with rare hereditary galactose intolerance, Lapp lactase deficiency, and glucose galactose malabsorption.
It should not be used to drive machines, vehicles, ships, engage in aerial work, mechanical work and operation of precision instruments during the period of taking the drug; elderly patients should be regularly monitored blood pressure during the period of using the drug; patients with prostatic hypertrophy or paralytic intestinal obstruction and other related diseases should be cautious; pregnant women and lactating women should be cautious about the use of the drug.
If medication is needed, it should be used under the guidance of a specialist.